Next Article in Journal
Experimental Confirmation of a Whole Set of tRNA Molecules in Two Archaeal Species
Previous Article in Journal
Molecular Characterization of a New Wheat-Thinopyrum intermedium Translocation Line with Resistance to Powdery Mildew and Stripe Rust
Previous Article in Special Issue
Formins: Linking Cytoskeleton and Endomembranes in Plant Cells
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2015, 16(1), 2174-2186; doi:10.3390/ijms16012174

Transgenic Plants as Low-Cost Platform for Chemotherapeutic Drugs Screening

1
Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Campus ECOTEKNE, S.P. 6, Lecce-Monteroni, Lecce 73100, Italy
2
Laboratory of Clinical Proteomics, Vito Fazzi Hospital, Lecce 73100, Italy
3
Institute of Science of Food Production, National Research Council (CNR), Lecce 73100, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Marcello Iriti
Received: 30 November 2014 / Accepted: 9 January 2015 / Published: 20 January 2015
(This article belongs to the Special Issue Plant Cell Compartmentation and Volume Control)
View Full-Text   |   Download PDF [2734 KB, uploaded 20 January 2015]   |  

Abstract

In this work we explored the possibility of using genetically modified Arabidopsis thaliana plants as a rapid and low-cost screening tool for evaluating human anticancer drugs action and efficacy. Here, four different inhibitors with a validated anticancer effect in humans and distinct mechanism of action were screened in the plant model for their ability to interfere with the cytoskeletal and endomembrane networks. We used plants expressing a green fluorescent protein (GFP) tagged microtubule-protein (TUA6-GFP), and three soluble GFPs differently sorted to reside in the endoplasmic reticulum (GFPKDEL) or to accumulate in the vacuole through a COPII dependent (AleuGFP) or independent (GFPChi) mechanism. Our results demonstrated that drugs tested alone or in combination differentially influenced the monitored cellular processes including cytoskeletal organization and endomembrane trafficking. In conclusion, we demonstrated that A. thaliana plants are sensitive to the action of human chemotherapeutics and can be used for preliminary screening of drugs efficacy. The cost-effective subcellular imaging in plant cell may contribute to better clarify drugs subcellular targets and their anticancer effects. View Full-Text
Keywords: Arabidopsis thaliana; chemotherapeutics; cytoskeleton; endomembrane trafficking; green fluorescent protein Arabidopsis thaliana; chemotherapeutics; cytoskeleton; endomembrane trafficking; green fluorescent protein
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Vergara, D.; de Domenico, S.; Maffia, M.; Piro, G.; Sansebastiano, G.-P.D. Transgenic Plants as Low-Cost Platform for Chemotherapeutic Drugs Screening. Int. J. Mol. Sci. 2015, 16, 2174-2186.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top